cbdMD (YCBD) EBT Margin (2016 - 2025)

cbdMD (YCBD) reported EBT Margin of 5.64% for Q4 2025, down 594.0% on a YoY basis from 1.14% in Q4 2024, and up 60.82% sequentially from 14.4% in Q3 2025.

cbdMD (YCBD) EBT Margin (2016 - 2025) Analysis & Trends

cbdMD (YCBD) has 10 years of EBT Margin data on file, last reported at 5.64% in Q4 2025.

  • For the quarter ending Q4 2025, EBT Margin fell 594.0% year-over-year to 5.64%; the trailing twelve-month figure through Dec 2025 stood at 12.25% (up 142.0% YoY), and the FY2025 full-year result was 10.63%, up 794.0% from the prior year.
  • EBT Margin advanced to 5.64% in Q4 2025, from 14.4% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 14.45% in Q2 2021 to a low of 368.14% in Q2 2022.
  • A 5-year average of 72.75% and a median of 25.18% in 2023 frame the typical range for EBT Margin.
  • Across the five-year window, EBT Margin slumped 38259 bps in 2022 and surged 33921 bps in 2023, its largest moves.
  • Tracing YCBD's EBT Margin over 5 years: stood at 194.39% in 2021, then surged by 67 bps to 63.39% in 2022, then jumped by 71 bps to 18.54% in 2023, then surged by 102 bps to 0.3% in 2024, then plunged by 2012 bps to 5.64% in 2025.
  • Business Quant data shows YCBD's EBT Margin at 5.64% in Q4 2025, 14.4% in Q3 2025, and 19.43% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 10.97%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 33.51%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -41.57%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 40.73%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -7.05%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 30.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.35%
10 cbdMD 438,678.80 -2.95 Mn 3.00 Mn -5.64%

Historic Data

Download Data
DateValue
Dec 31, 2025 -5.64%
Sep 30, 2025 -14.40%
Jun 30, 2025 -19.43%
Mar 31, 2025 -10.12%
Dec 31, 2024 0.30%
Sep 30, 2024 -3.06%
Jun 30, 2024 8.89%
Mar 31, 2024 -68.79%
Dec 31, 2023 -18.54%
Sep 30, 2023 -326.16%
Jun 30, 2023 -28.93%
Mar 31, 2023 -21.42%
Dec 31, 2022 -63.39%
Sep 30, 2022 -152.74%
Jun 30, 2022 -368.14%
Mar 31, 2022 -48.37%
Dec 31, 2021 -194.39%
Sep 30, 2021 -30.38%
Jun 30, 2021 14.45%
Mar 31, 2021 -104.73%